Comparator populations are a new point of emphasis for device approval "since the epidemiologists took over the PAS program."

— A comment by Danica Marinac-Dabic, chief of FDA's Office of Surveillance and Biometrics, "Hologic gets panel approval for Adiana contraceptive device," pp. 1, 7.